UBS Group’s Estrella Immunopharma ESLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Buy |
72,773
+31,739
| +77% | +$30.5K | ﹤0.01% | 6241 |
|
|
2025
Q1 | $38K | Sell |
41,034
-24,133
| -37% | -$22.4K | ﹤0.01% | 6491 |
|
|
2024
Q4 | $78.2K | Buy |
65,167
+58,644
| +899% | +$70.4K | ﹤0.01% | 5813 |
|
|
2024
Q3 | $7.57K | Buy |
+6,523
| New | +$7.57K | ﹤0.01% | 6684 |
|
|
2024
Q1 | – | Sell |
-303
| Closed | -$336 | – | 8232 |
|
|
2023
Q4 | $336 | Buy |
+303
| New | +$336 | ﹤0.01% | 7502 |
|
|
2023
Q1 | – | Sell |
-756
| Closed | -$7.78K | – | 8600 |
|
|
2022
Q4 | $7.78K | Buy |
756
+310
| +70% | +$3.19K | ﹤0.01% | 7667 |
|
|
2022
Q3 | $4K | Buy |
+446
| New | +$4K | ﹤0.01% | 8243 |
|